Similar articles for PMID: 11990646

Year	Number of Results
2001	7
2002	5
2003	8
2004	15
2005	8
2006	10
2007	5
2008	12
2009	10
2010	7
2011	7
2012	8
2013	11
2014	8
2015	6
2017	3
2018	2
2022	2
2024	0

1

Advances in treatment of chronic hepatitis C: 'pegylated' interferons.

Sharieff KA, Duncan D, Younossi Z. Sharieff KA, et al. Cleve Clin J Med. 2002 Feb;69(2):155-9. doi: 10.3949/ccjm.69.2.155. Cleve Clin J Med. 2002. PMID: 11990646 Free article. Review.

2

Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.

Hauser G, Awad T, Brok J, Thorlund K, Štimac D, Mabrouk M, Gluud C, Gluud LL. Hauser G, et al. Cochrane Database Syst Rev. 2014 Feb 28;(2):CD005441. doi: 10.1002/14651858.CD005441.pub3. Cochrane Database Syst Rev. 2014. PMID: 24585509 Review.

3

Pegylated interferons: what role will they play in the treatment of chronic hepatitis C?

Shiffman ML. Shiffman ML. Curr Gastroenterol Rep. 2001 Feb;3(1):30-7. doi: 10.1007/s11894-001-0038-z. Curr Gastroenterol Rep. 2001. PMID: 11177692 Review.

4

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. Fried MW, et al. N Engl J Med. 2002 Sep 26;347(13):975-82. doi: 10.1056/NEJMoa020047. N Engl J Med. 2002. PMID: 12324553 Free article. Clinical Trial.

5

The evolving treatment of chronic hepatitis C: where we stand a decade out.

Saadeh S, Davis GL. Saadeh S, et al. Cleve Clin J Med. 2004 May;71 Suppl 3:S3-7. doi: 10.3949/ccjm.71.suppl_3.s3. Cleve Clin J Med. 2004. PMID: 15468610 Free article. Review.

6

Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C.

Ishiguro H, Abe H, Seki N, Sugita T, Aida Y, Itagaki M, Sutoh S, Shimada N, Furihata T, Tsubota A, Aizawa Y. Ishiguro H, et al. World J Gastroenterol. 2015 Apr 7;21(13):3904-11. doi: 10.3748/wjg.v21.i13.3904. World J Gastroenterol. 2015. PMID: 25852275 Free PMC article.

7

Soluble interleukin 2 receptor plasma levels in non-responders with chronic hepatitis C treated with pegylated interferon-alpha 2b and ribavirin.

Henke H, Schmiegel W, Brechmann T, Voigt E, Griga T. Henke H, et al. J Clin Gastroenterol. 2004 Mar;38(3):301-3. doi: 10.1097/00004836-200403000-00025. J Clin Gastroenterol. 2004. PMID: 15128086 No abstract available.

8

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, Benzekri A, Morand P, Goujard C, Pialoux G, Piroth L, Salmon-Céron D, Degott C, Cacoub P, Perronne C; ANRS HCO2 RIBAVIC Study Team. Carrat F, et al. JAMA. 2004 Dec 15;292(23):2839-48. doi: 10.1001/jama.292.23.2839. JAMA. 2004. PMID: 15598915 Clinical Trial.

9

Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?

Zeuzem S. Zeuzem S. Ann Intern Med. 2004 Mar 2;140(5):370-81. doi: 10.7326/0003-4819-140-5-200403020-00033. Ann Intern Med. 2004. PMID: 14996679 Review.

10

[Durability of sustained virologic response in chronic hepatitis C: analysis of factors related to relapse after sustained virologic response with peginterferon plus ribavirin combination therapy].

Lee JE, Yoon NR, Kim JD, Song MJ, Kwon JH, Bae SH, Choi JY, Jeong SW, Yoon SK. Lee JE, et al. Korean J Gastroenterol. 2011 Mar;57(3):173-9. doi: 10.4166/2011.57.3.173. Korean J Gastroenterol. 2011. PMID: 21519165 Free article. Korean.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

125 results

Results by year